Tag Archives: IMMU

Blue Horseshoe Stocks: SIG Recap, AXON & More

Posted on by

Signet Jewelers Ltd. SIG – Options Idea

After noticing its solid beat on earnings and reassured guidance yesterday morning in the premarket, we selected a range of options ideas for the SIG chain. Post-earnings options calls have become our bread and butter, and SIG provided yet another example of the reason for that.

Our designated observation range was the SIG Weekly $47.50-50 Calls and all but the 49.50′s enjoyed considerable single-session gains for the day.

$47.50 Calls – Range: 3.70-6.30 – Max Gain: 70%
$48 Calls – Range: 3.21-7.12 – Max Gain: 122%
$48.50 Calls – Range: 3.10-6.00 – Max Gain: 94%
$49 Calls – Range: 2.72-6.17 – Max Gain: 127%
$50 Calls – Range: 1.97-5.21 – Max Gain: 164%
___________

Fresh Options Idea:
Five Below, Inc. FIVE Weekly $90-95 Calls

Axovant Sciences, Inc. AXON

We also included a tag of AXON in yesterday morning’s report, and were met with a pretty good chance for a daily profit there as well. We noticed a slew of Form-4 buys come in on Tuesday, and lo and behold, yesterday the company released news of an $840M+ licensing deal for its Parkinson’s gene therapy.

From a morning low of 3.27, the stock reached a high of 4.64, representing a modest, but very respectable 42% move on the day. We’ll be sure to leave it on our radar in the event that a more sustained move is in the cards.

Extended Watchlist:
ONTX, MRTX, ZS, IMMU, CLWT, CLSD, CLRB

Blue Horseshoe Stocks: TJX Review & More

Posted on by


Petroleo Brasiliero SA (Petrobras) PBR

As we kick off a fresh trading week, we’re drawn to a familiar stock from the past in PBR. Our relationship in following and making successful calls with this play stretches back for years,

Recently, the stock had been falling on the heels of a solid run last month, and that decline was kicked into a higher gear last week as the company’s CEO resigned amid questions about the Brazilian economy. The turmoil has brought PBR to its lowest levels and most oversold point since December, as you can see on the chart below.

You can also see that those conditions led to a month-long run of considerable proportions, so we’re going to want to signal some longer-term options in case the pattern were to repeat itself. We’ll place the PBR 06/29 $11-12 Calls on watch in the days and weeks ahead.


The TJX Companies, Inc. TJX – Recap

We presented some longer term options ideas in our report from May 22nd as well, and wanted to update our readers on the fantastic gains that have been made possible by the stock’s continuous bull run since that time.

Our targets were the TJX 06/15 $85-90 Calls, and the excellent moves made by those contracts are as follows:

$85 Calls – Range: 2.14-6.30 – Max Gain: 194%
$87.50 Calls – Range: .90-3.80 – Max Gain: 322%
$90 Calls – Range: .35-2.00 – Max Gain: 471%

Extended Watchlist:
ATIS, AXON, MUSZ, ENT, EOLS, MRNS, IMMU

Blue Horseshoe Stocks: WMT Options & More

Posted on by

Walmart, Inc. WMT – Options Idea

Walmart was already building a nice head of steam on the chart in the weeks leading up to this morning’s earnings release. Things have kicked up a notch this morning as Walmart recorded a resounding across-the-board beat, including an online sales increase of 33%

Given that we are always looking out for opportunities to trade options on the heels of a solid earnings beat, we are going to slate some Walmart calls for observation this morning.

We’ll be tracking the WMT Weekly $86.50-88.50 Calls after what we expect should be a dip-and-rip scenario.

Altimmune, Inc. ALT

We would also like to make mention of ALT this morning, after taking notice of the significant pickup in both price action and volatility yesterday.

That was preceded by a lengthy consolidation period as you can see on the snapshot below, and at the present time, the stock is beginning to come off of being oversold. We’ll watch this one for a potential recovery play in upcoming sessions.
—

Extended Watchlist:
BDSI, BIOC, BLNK, IMMU, FRED, NOG

Blue Horseshoe Stocks: ALQA Recap & More

Posted on by

Alliqua, Inc. ALQA

The big winner off our premarket watchlist in yesterday’s report turned out to be ALQA, which had a hard spike early in the session and continued to push more steadily upward over the course of the day leading to a strong close. The activity was fueled by the news that the FDA granted 510(k) clearance for ALQA’a SilverSeal Hydrogel wound dressing.

From its early low of .258 the stock traversed its way up to .45, which goes down as a 74% intraday gain. The move came on nearly forty times the monthly average volume on the stock, and as we just mentioned, it also closed with strength, just a penny below the high of day.

After hours trading also saw the stock achieve a high of .51, and it appears as if it could gap up slightly to start the day. We’ll be on the lookout for signs of a continued uptrend here as we head into this midweek.

Uni-Pixel, Inc. UNXL

Despite looming bankruptcy proceedings for UNXL, our bottom-feeder instincts have kicked in as the stock was punished down to a new all-time lows yesterday and is showing signs of a possible rebound this morning.

This NASDAQ could certainly be on its way to an OTC Markets listing in the future, being nowhere near the minimum bid requirements for the higher exchange. But for the time being, we’re only interested in its immediate situation. Over-abused stocks have had a historical tendency to produce some very nice moves for us as they correct course, so we’re going to place UNXL on watch in coming days.

Rimrock Gold Corp. RMRK

We also wanted to swing back around for a quick update on RMRK this morning. We placed this one on watch last Wednesday morning, catching it before it ran over 300% from .0006-.0025 that afternoon.

After a sharp pullback to .0008 over the ensuing few sessions, the stock  rebounded yesterday, returning to a high of .0019 which marks a 138% swing.

We’ll be watching for it to continue to register higher lows on any further pullbacks. Any stock with this kind of price action and volatility is one that we definitely want to keep a close eye on for more quick strike trade opportunities.

Extended Watchlist:
ABCO, IMGN, IMMU, SBGL, RTNB, ETRM, MBRX

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Posted on by


Potential Rebound Plays

U.S. Stem Cell, Inc. USRM  -We caught USRM for some nice gain opportunities a couple of weeks back. We had initially begun tracking this play after mentioning it on the morning of February 27th. Subsequent to that, we had witnessed an impressive run from a low of .014  to .0545, for a 289% gain in a span of just two sessions.

That was followed by an expected period of consolidation, but it appears as if USRM has found support at .0175. We’re going to want to return to monitoring this play more closely on the chance that it could be gearing up for another run. If it produced a move even a fraction of what we saw before, it will be worth its slot on our watchscreens.

______

Iconic Brands, Inc. ICNB – Speaking of familiar plays that could be in line for a rebound in upcoming sessions, we want to swing back around to ICNB this week. We had tracked this one to some decent gains after tagging it for observation on January 24th. Following that, the stock would trade in a range from .018 up to .0339, a respectable move of 88%

But like the above-mentioned stock, after its run, it basically underwent a big-time consolidation which lasted nearly a whole month. That brings us up to yesterday, when we noticed ICNB giving off something of a rebound signal. We’ll go back to watching more closely in the next few sessions.

Aralez Pharmaceuticals, Inc. ARLZ – Bottom Watcher

ARLZ has been falling off a cliff this week, and despite the fact that it may yet have further to fall, we’re going to want to begin monitoring it as it attempts to sniff out a solid support level. There could definitely be some opportunities waiting for traders that can properly time the recovery.


Direxion Daily Jr Gld Mnrs Bull 3X ETF  (JNUG) – Reminder

Apart from some quick chances for early gains yesterday, our freshly formulated options idea for JNUG may need some time to mature. That’s why we chose an expiration date a couple of weeks out. We’ll continue to have the JNUG 03/31 $7-8 Calls on our radars moving forward.

Extended Watchlist:
DTII, AVXL, AXAS, OWCP, SPCL, IMMU, CVRS